Canntab Therapeutics Limited (TBF1.F)
| Previous Close | 0.5100 |
| Open | 0.5250 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.5250 - 0.5250 |
| 52 Week Range | 0.1590 - 0.7150 |
| Volume | 3,000 |
| Avg. Volume | 79 |
| Market Cap | 18.384M |
| Beta (5Y Monthly) | 1.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0870 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
Canntab Announces Closing of Convertible Debenture Private Placement
Toronto, Ontario--(Newsfile Corp. - December 31, 2020) - Canntab Therapeutics Limited. (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) ("Canntab" or the "Company"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the closing of a non-brokered private placement (the "Offering") of secured convertible debentures of the Company ("Convertible Debentures"), pursuant to which the Company issued Convertible Debentures for gross proceeds of $1,575,000 (the "Convertible Debentures"). The ...
- CNW Group
Canadian securities regulators seek comment on activist short selling
TORONTO, Dec. 3, 2020 /CNW/ - The Canadian Securities Administrators (CSA) today published a consultation paper to facilitate discussion about activist short selling.
- CNW Group
COVID-19 Pandemic - The government presents its daily update
QUÉBEC CITY, Nov. 28, 2020 /CNW Telbec/ - The most recent data on the evolution of COVID-19 in Québec show 1,480 new cases, bringing the total number of people infected to 139,643.
